On Invalid Date, Assertio Holdings (NASDAQ: ASRT) reported Q2 2023 earnings per share (EPS) of $0.15, up 11.76% year over year. Total Assertio Holdings earnings for the quarter were $8.47 million. In the same quarter last year, Assertio Holdings's earnings per share (EPS) was $0.17.
As of Q3 2023, Assertio Holdings's earnings has grown 266.07% year over year. This is 202.98 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry earnings growth rate of 63.09%. Assertio Holdings's earnings in the past year totalled $97.71 million.
What is ASRT's earnings date?
Assertio Holdings's earnings date is Invalid Date. Add ASRT to your watchlist to be reminded of ASRT's next earnings announcement.
What was ASRT's revenue last quarter?
On Invalid Date, Assertio Holdings (NASDAQ: ASRT) reported Q2 2023 revenue of $40.99 million up 16.68% year over year. In the same quarter last year, Assertio Holdings's revenue was $35.13 million.
What was ASRT's revenue growth in the past year?
As of Q3 2023, Assertio Holdings's revenue has grown 28.78% year over year. This is 17.55 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 11.23%. Assertio Holdings's revenue in the past year totalled $168.02 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.